911 Blog posts found


Uncertainties about Clinical Trials Keep Patients from Enrolling

Most people are aware of how important clinical trials are and how they can lead to lifesaving breakthroughs, but they’re also unlikely to participate in them.

A young female doctor in a white coat sits with an older male patient in an exam room

In the Clinic

Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma

The immunotherapy drug nivolumab is now approved for patients whose Hodgkin lymphoma has failed other treatments.

A Hodgkin lymphoma survivor who received nivolumab as part of a clinical trial.

In the Clinic

FDA Approves “Game Changer” Immunotherapy Drug for Bladder Cancer

The FDA approved the immunotherapy drug atezolizumab for people with metastatic urothelial bladder cancer, the first new treatment for this form of the disease in more than 20 years.

Bladder cancer survivor and his wife on a sailboat.


The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting developments researchers at Memorial Sloan Kettering have made in the fight against cancer.

DNA molecules wrapped around histones

In the Clinic

Robot-Assisted Surgery at MSK Helps a Growing Number of Patients

MSK performs the highest number of robot-assisted surgeries in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.

A man standing with his wife and three sons.


Is Chemo Brain Real?

Cancer treatments like chemotherapy may cause cognitive changes, which experts call “chemo brain.” Learn how Memorial Sloan Kettering experts help patients with this condition.

author finds help for chemo brain


6 Myths about Testicular Cancer

Separate fact from fiction regarding testicular cancer.

Man examining himself.

In the Clinic

When Heartburn Signals Cancer Risk

Many people don’t know that gastroesophageal reflux disease (GERD) is a potentially serious condition that — if left untreated — can ultimately lead to esophageal cancer.

Older man talking with a doctor.

In the News

At #AACR16, Vice President Biden Unveils ‘Moonshot’ Goal: A Decade’s Worth of Progress in Five Years

The 2016 annual meeting of the American Association for Cancer Research (AACR) ended with a visit from the Vice President.


News from #AACR16: Precision Medicine Progress, Turbocharged CARs, and Turning Up the Heat against Cancer

At the 2016 American Association for Cancer Research (AACR) conference, there were clear signs that cancer treatment is evolving from a slash-and-burn method to a more precisely targeted, intelligent approach.

José Baselga